Target intelligence / Profile preview

Protein DDI1 homolog 1 (DDI1)

Target
DDI1
Molecular classification
Enzyme, Aspartic protease, Ubiquitin-like domain protein, Proteasomal shuttle protein
01

Overview

Protein DDI1 homolog 1 (DDI1) is a ubiquitin-dependent protease and proteasomal shuttle factor that plays a unique role in protein quality control and cellular homeostasis[4][1]. DDI1 contains three major domains: a ubiquitin-like (UBL) domain, a retroviral protease-like (RVP) domain, and often a ubiquitin-associated (UBA) domain, though the latter is absent in mammals[1][3][4]. The RVP domain structurally resembles retroviral proteases but is distinct in its requirement for substrate polyubiquitylation: DDI1 protease activity is only triggered when substrate proteins are tagged with long polyubiquitin chains (>8 ubiquitins)[4]. DDI1 mediates the degradation or processing of polyubiquitinated proteins, working synergistically with the proteasome, and can cleave specific substrates under stress or when proteasomal function is impaired[4]. DDI1 and its mammalian homologs (such as DDI2) also play a role in the regulation of the transcription factor Nrf1, which controls the expression of proteasome subunits and adaptation to proteotoxic stress[4]. There is growing interest in DDI1 as a potential therapeutic target in oncology, infection (notably malaria, as in Plasmodium falciparum), and potential resistance mechanisms to proteasome inhibitors, due to its unique substrate specificity and structural similarity to viral proteases[4][1][5].

Other names
DDI proteasomal shuttling factor 1DDI1DNA-damage inducible 1 homolog 1DNA-damage inducible protein 1FLJ36017
02

Mechanism of action

Inhibition of retroviral protease-like (RVP) domain (as for nelfinavir)

03

Biological functions

Proteasomal degradationUbiquitin-dependent proteolysisDNA damage responseProtein processing and quality control
04

Disease associations

CancerNeurodegenerative diseaseInfection
05

Safety considerations

Potential off-target effects due to homology with retroviral proteasesImpact on general proteostasis (protein homeostasis), which can affect viability of non-target cells
06

Interacting drugs

Nelfinavir (HIV protease inhibitor shown to affect DDI1 activity in experimental models)
07

Biomarkers

Accumulation of polyubiquitinated proteins (as indicator of impaired DDI1 function)

Beyond the preview

Go deeper on Protein DDI1 homolog 1 (DDI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein DDI1 homolog 1 (DDI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call